Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®

被引:13
作者
Hartwig, Susanne [1 ]
Uhari, Matti [2 ]
Renko, Marjo [2 ]
Bertet, Perrine [1 ]
Hemming, Maria [3 ]
Vesikari, Timo [3 ]
机构
[1] Sanofi Pasteur MSD, Dept Epidemiol, Lyon, France
[2] Univ Oulu, Dept Paediat, Oulu, Finland
[3] Univ Tampere, Sch Med, Vaccine Res Ctr, FIN-33101 Tampere, Finland
来源
BMC HEALTH SERVICES RESEARCH | 2014年 / 14卷
关键词
PLACEBO-CONTROLLED TRIAL; EMERGENCY-DEPARTMENT; ECONOMIC-EVALUATION; DISEASE BURDEN; CHILDREN; IMPACT; COUNTRIES; CARE; INFECTIONS; OUTBREAKS;
D O I
10.1186/s12913-014-0632-z
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Vaccination-impact studies of the live-attenuated pentavalent oral vaccine Rotateq (R) have demonstrated that the burden of rotavirus gastroenteritis has been reduced significantly after the introduction of RotaTeq (R) vaccination, but less is known about the benefit of this vaccination on hospital overcrowding. Methods: As part of an observational surveillance conducted during the RV seasons 2000/2001 to 2011/2012, we analysed hospital discharge data collected retrospectively from two Finnish hospitals (Oulu and Tampere), concerning ICD 10 codes A00-09 (acute gastroenteritis, AGE) and A08.0 (rotaviral acute gastroenteritis RV AGE). We estimated the reduction in the number of beds occupied and analysed the bed occupancy rate, for RV AGE and all cause AGE, among 0-16 year-old children, before and after the implementation of the RV immunisation program. Results: The rate of bed days occupied for RV AGE was reduced by 86% (95% CI 66%-94%) in Tampere and 79% (95% CI 47%-92%) in Oulu after RV vaccination implementation. For all cause AGE, reduction was 50% (95% CI 29% to 65%) in Tampere and 70% (95% CI 58% to 79%) in Oulu. Results were similar among 0-2 year-old children. This effect was also observed on overcrowding in both hospitals, with a bed occupancy rate for all cause AGE >25% in only 1% of the time in Tampere and 9% in Oulu after the implementation of the immunisation program, compared to 13% and 48% in the pre-vaccination period respectively. After extrapolation to the whole country, the annual number of prevented hospitalizations for all cause AGE in the post-vaccination period in Finland was estimated at 1,646 and 2,303 admissions for 0-2 and 0-16 year-old children respectively. Conclusions: This study demonstrated that universal RV vaccination is associated with a clear decrease in the number of bed days and occupancy rates for RV AGE and all cause AGE. Positive consequences include increase in quality of care and a better healthcare management during winter epidemics.
引用
收藏
页数:9
相关论文
共 43 条
[1]   Simultaneous outbreaks of rotavirus and respiratory syncitial virus in Paris: a 12-year survey [J].
Armengaud, J.-B. ;
El Hajje, M. J. ;
Moulin, F. ;
Marc, E. ;
Chalumeau, M. ;
Lebon, P. ;
Gendrel, D. .
MEDECINE ET MALADIES INFECTIEUSES, 2007, 37 (05) :262-265
[2]   Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales [J].
Atchison, Christina ;
Lopman, Ben ;
Edmunds, William John .
VACCINE, 2010, 28 (18) :3118-3126
[3]   Bed occupancy and overcrowding as determinant factors in the incidence of MRSA infections within general ward settings [J].
Borg, MA .
JOURNAL OF HOSPITAL INFECTION, 2003, 54 (04) :316-318
[4]   ETHICAL ISSUES OF HOSPITAL CROWDING SOLUTIONS [J].
Braun, Brenda .
JOURNAL OF EMERGENCY NURSING, 2011, 37 (04) :381-385
[5]   Rotavirus-related Hospitalizations Are Responsible for High Seasonal Peaks in All-cause Pediatric Hospitalizations [J].
Bruijning-Verhagen, Patricia ;
Sankatsing, Valerie ;
Kunst, Annemieke ;
van den Born, Charlie ;
Bleeker, Esther ;
Thijsen, Steven ;
Ijzerman, Ed P. F. ;
van der Velden, Vincent H. J. ;
Bonten, Marc J. M. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (12) :E244-E249
[6]   Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain [J].
Castilla, Jesus ;
Beristain, Xabier ;
Martinez-Artola, Victor ;
Navascues, Ana ;
Garcia Cenoz, Manuel ;
Alvarez, Nerea ;
Polo, Isabel ;
Mazon, Ana ;
Gil-Setas, Alberto ;
Barricarte, Aurelio .
VACCINE, 2012, 30 (03) :539-543
[7]   Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program [J].
Dey, Aditi ;
Wang, Han ;
Menzles, Robert ;
Macartney, Kristine .
MEDICAL JOURNAL OF AUSTRALIA, 2012, 197 (08) :453-457
[8]   Use of vaccines as probes to define disease burden [J].
Feikin, Daniel R. ;
Scott, J. Anthony G. ;
Gessner, Bradford D. .
LANCET, 2014, 383 (9930) :1762-1770
[9]   Acute gastro-enteritis in children in France: estimates of disease burden through national hospital discharge data [J].
Fourquet, F ;
Desenclos, JC ;
Maurage, C ;
Baron, S .
ARCHIVES DE PEDIATRIE, 2003, 10 (10) :861-868
[10]   Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: The IVANHOE study [J].
Gagneur, Arnaud ;
Nowak, Emmanuel ;
Lemaitre, Thomas ;
Segura, Jean-Francois ;
Delaperriere, Nadege ;
Abalea, Lydie ;
Poulhazan, Elise ;
Jossens, Anne ;
Auzanneau, Lucie ;
Tran, Adissa ;
Payan, Christopher ;
Jay, Nadine ;
de Parscau, Loic ;
Oger, Emmanuel .
VACCINE, 2011, 29 (21) :3753-3759